<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>januarythirtietheightk.txt
<TEXT>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 30,
2003
JOHNSON & JOHNSON
(Exact name of registrant as specified in its charter)
New Jersey 1-3215 22-1024240
(State or other Commission (I.R.S. Employer
jurisdiction File Number) Identification No.)
of incorporation)
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933
(Address of principal executive offices) (zip code)
Registrant's telephone number including area code: (732) 524-0400
Item 5. Other Events.
On January 24, 2003, Johnson & Johnson ("J&J") issued a press
release statement on the Amgen arbitration fees and expenses.
Exhibit 99.15 of this Form 8K reflects this press release amended
to include the accrual of the Amgen arbitration and fees recorded
as part of 2002 financial results. The unaudited consolidated
statements of earnings of J&J for the fourth quarter and year
ended December 29, 2002 reflecting the results of the Amgen
arbitration fees and expenses is being filed as Exhibit 99.2O to
this Form 8K.
On January 22, 2003, John Snow resigned from the Board of
Directors in connection with his nomination by President Bush to
serve as U.S. Secretary of the Treasury.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits
Exhibit No. Description of Exhibit
99.15 Press Release on Amgen arbitration fees and expenses.
99.2O Unaudited consolidated statements of earnings
for the fourth quarter and year ended December
29, 2002
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
JOHNSON & JOHNSON
Date: January 30, 2003 By: /s/ Stephen J. Cosgrove
Stephen J. Cosgrove
Chief Accounting Officer
</TEXT>
</DOCUMENT>